CTRI/2021/04/033214招募中2 期
Pilot study of leflunomide as first line therapy for musculoskeletal GVHD
Dr Sachin Punatar0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Willing to give written informed consent
- •2. Patients diagnosed with musculoskeletal mGvHD based on 2014 NIH consensus criteria (with diagnosis confirmed by biopsy only if clinically required).
- •3. Willing and able to comply with all study requirements, including treatment, and periodic assessments.
排除标准
- •1. Patients with known hypersensitivity to leflunomide especially previous Steven Johnson syndrome, toxic epidermal necrolysis after leflunomide.
- •2. Pregnant females
- •3. Patients with musculoskeletal manifestations explained by other potential causes (drugs, trauma, etc).
- •4. Patients with calculated GFR <30ml/min at the time of screening.
研究者
相似试验
已完成
1 期
Leflunomide in Treating Patients With Relapsed or Refractory Multiple MyelomaRecurrent Plasma Cell MyelomaRefractory Plasma Cell MyelomaNCT02509052City of Hope Medical Center12
已完成
不适用
A pilot study to assess flutamide monotherapy compared With maximal androgen blockade in metastatic prostate cancerCancerProstate cancerISRCTN92984394Schering-Plough Ltd (UK)
已完成
1 期
Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent MalignancyHematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSymptomatic COVID-19 Infection Laboratory-ConfirmedNCT04532372City of Hope Medical Center2
招募中
不适用
A pilot study to evaluate the efficacy of lafutidine in patients with paclitaxel-induced peripheral neuropathy.gynecological cancerJPRN-UMIN000011890Fukushima medical University Hospital, School of medicine30
尚未招募
2 期
eflunomide to prevent Cytomegalovirus infection in Bone marrow transplantatioCTRI/2017/06/008872Institutional support Academic study Christian Medicaol College Vellore50